Insider · CIK 0001339402

Driscoll Martin J

Reports to the SEC for 4 companies · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001339402

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2020-11-20	F-star Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−175 sh	$4.76	−$833	47,425
2020-11-19	F-star Therapeutics, Inc.WarrantsJ Other	Director, President and CEO	JOther	−5,475 sh	—	—	0
2020-11-19	F-star Therapeutics, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+10K sh	—	—	32,600
2020-11-19	F-star Therapeutics, Inc.A Award	Director, President and CEO	AAward	+15K sh	—	—	47,600
2020-11-19	F-star Therapeutics, Inc.Restricted Stock UnitsM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−10K sh	—	—	0
2020-03-05	F-star Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+40K sh	—	—	40,000
2020-03-05	F-star Therapeutics, Inc.Restricted Stock UnitsA Award	Director, President and CEO	AAward	+40K sh	—	—	40,000
2019-11-13	F-star Therapeutics, Inc.P Purchase	Director, President and CEO	PPurchase	+5,000 sh	$2.83	+$14.2K	90,400
2019-05-29	F-star Therapeutics, Inc.P Purchase	Director, President and CEO	PPurchase	+10K sh	$6.03	+$60.3K	85,400
2019-05-21	F-star Therapeutics, Inc.P Purchase	Director, President and CEO	PPurchase	+5,000 sh	$6.63	+$33.2K	75,400
2019-04-30	F-star Therapeutics, Inc.P Purchase	Director, President and CEO	PPurchase	+5,000 sh	$7.31	+$36.6K	65,400
2019-04-30	F-star Therapeutics, Inc.P Purchase	Director, President and CEO	PPurchase	+5,000 sh	$7.36	+$36.8K	70,400
2019-01-24	F-star Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+50K sh	—	—	50,000
2018-08-13	F-star Therapeutics, Inc.P Purchase	Director, President and CEO	PPurchase	+4,000 sh	$12.02	+$48.1K	60,400
2018-02-28	F-star Therapeutics, Inc.P Purchase	Director, President and CEO	PPurchase	+1,000 sh	$12.83	+$12.8K	56,400
2018-01-16	F-star Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+80K sh	—	—	80,000
2017-09-14	F-star Therapeutics, Inc.P Purchase	Director, President and CEO	PPurchase	+1,000 sh	$14.84	+$14.8K	55,400
2017-08-03	F-star Therapeutics, Inc.P Purchase	Director, President and CEO	PPurchase	+1,000 sh	$12.43	+$12.4K	54,400
2017-08-03	F-star Therapeutics, Inc.P Purchase	Director, President and CEO	PPurchase	+1,000 sh	$12.28	+$12.3K	53,400
2017-04-04	MetaStat, Inc.P Purchase	Director	PPurchase	+20K sh	—	—	49,616
2017-03-07	F-star Therapeutics, Inc.P Purchase	Director, President and CEO	PPurchase	+2,000 sh	$9.44	+$18.9K	52,400
2017-02-09	F-star Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+80K sh	—	—	80,000
2016-12-15	F-star Therapeutics, Inc.P Purchase	Director, President and CEO	PPurchase	+2,000 sh	$8.50	+$17K	50,400
2016-11-30	F-star Therapeutics, Inc.P Purchase	Director, President and CEO	PPurchase	+2,000 sh	$7.98	+$16K	48,400
2016-11-23	F-star Therapeutics, Inc.A Award	Director, President and CEO	AAward	+21.9K sh	$9.12	+$200K	46,400
2016-11-23	F-star Therapeutics, Inc.Warrant (right to buy)A Award	Director, President and CEO	AAward	+21.9K sh	—	—	21,900
2016-11-09	F-star Therapeutics, Inc.P Purchase	Director, President and CEO	PPurchase	+2,000 sh	$8.84	+$17.7K	24,500
2016-10-30	MetaStat, Inc.P Purchase	Director	PPurchase	+28.3K sh	$2.00	+$56.7K	29,616
2016-10-30	MetaStat, Inc.Series B Preferred StockJ Other	Director	JOther	−10.037 sh	$2.00	−$20.074	0
2016-10-30	MetaStat, Inc.WarrantsJ Other	Director	JOther	−4,546 sh	—	—	0
2016-10-30	MetaStat, Inc.WarrantsP Purchase	Director	PPurchase	+14.2K sh	—	—	14,171
2016-09-02	F-star Therapeutics, Inc.P Purchase	Director, President and CEO	PPurchase	+1,000 sh	$11.75	+$11.8K	22,500
2016-08-30	F-star Therapeutics, Inc.P Purchase	Director, President and CEO	PPurchase	+1,000 sh	$12.41	+$12.4K	21,500
2016-08-22	F-star Therapeutics, Inc.P Purchase	Director, President and CEO	PPurchase	+1,000 sh	$11.66	+$11.7K	20,500
2016-08-19	F-star Therapeutics, Inc.P Purchase	Director, President and CEO	PPurchase	+1,000 sh	$11.20	+$11.2K	19,500
2016-08-16	F-star Therapeutics, Inc.P Purchase	Director, President and CEO	PPurchase	+1,000 sh	$11.37	+$11.4K	18,500
2016-08-15	F-star Therapeutics, Inc.P Purchase	Director, President and CEO	PPurchase	+1,000 sh	$11.20	+$11.2K	17,500
2016-08-09	F-star Therapeutics, Inc.P Purchase	Director, President and CEO	PPurchase	+1,000 sh	$10.94	+$10.9K	15,500
2016-08-09	F-star Therapeutics, Inc.P Purchase	Director, President and CEO	PPurchase	+1,000 sh	$11.11	+$11.1K	16,500
2016-08-04	F-star Therapeutics, Inc.P Purchase	Director, President and CEO	PPurchase	+1,000 sh	$9.77	+$9,770	13,500
2016-08-04	F-star Therapeutics, Inc.P Purchase	Director, President and CEO	PPurchase	+1,000 sh	$10.15	+$10.2K	14,500
2016-05-19	F-star Therapeutics, Inc.Stock Option (right to buy)A Award	Director, President and CEO	AAward	+20K sh	—	—	20,000
2016-05-11	F-star Therapeutics, Inc.P Purchase	Director, President and CEO	PPurchase	+12.5K sh	$12.00	+$150K	12,500
2015-08-05	MetaStat, Inc.P Purchase	Director	PPurchase	+5,000 sh	$0.28	+$1,400	15,000
2015-08-05	MetaStat, Inc.P Purchase	Director	PPurchase	+4,100 sh	$0.27	+$1,107	19,100
2015-06-25	MetaStat, Inc.P Purchase	Director	PPurchase	+10K sh	$0.35	+$3,535	10,000
2015-05-18	MetaStat, Inc.Stock OptionsA Award	Director	AAward	+300K sh	—	—	300,000
2015-05-18	MetaStat, Inc.Stock OptionsA Award	Director	AAward	+300K sh	—	—	300,000
2010-07-02	JAVELIN PHARMACEUTICALS, INCStock Option (right to buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−5,000 sh	—	—	0
2010-07-02	JAVELIN PHARMACEUTICALS, INCD Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−180K sh	$2.20	−$395K	0

Recent filings

Accepted (ET)
Nov 234
Driscoll Martin J0000905718-20-001131
SEC(opens sec.gov)
Mar 94
Driscoll Martin J0001209191-20-017232
SEC(opens sec.gov)
Nov 144
Driscoll Martin J0001209191-19-056502
SEC(opens sec.gov)
May 294
Driscoll Martin J0001209191-19-033137
SEC(opens sec.gov)
May 224
Driscoll Martin J0001209191-19-031916
SEC(opens sec.gov)
Apr 304
Driscoll Martin J0001209191-19-026537
SEC(opens sec.gov)
Jan 254
Driscoll Martin J0001209191-19-005452
SEC(opens sec.gov)
Aug 134
Driscoll Martin J0001209191-18-046392
SEC(opens sec.gov)
Mar 14
Driscoll Martin J0001209191-18-014937
SEC(opens sec.gov)
Jan 174
Driscoll Martin J0001209191-18-003917
SEC(opens sec.gov)
Sep 144
Driscoll Martin J0001209191-17-052800
SEC(opens sec.gov)
Aug 34
Driscoll Martin J0001209191-17-047285
SEC(opens sec.gov)
Apr 64
MetaStat, Inc.0001415889-17-000623
SEC(opens sec.gov)

Companies

Address

C/O JAVELIN PHARMACEUTICALS 125 CAMBRIDGEPARK DRIVE

CAMBRIDGE, MA, 02140